Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **coagulation system**, often referred to as the **coagulation cascade**, is a complex series of enzymatic reactions involving plasma proteins (mainly serine proteases, cofactors, and glycoproteins) that control blood clotting to achieve hemostasis[1][2][4][3][5]. The process is initiated by either the tissue factor (extrinsic) pathway or the contact activation (intrinsic) pathway, both converging on the common pathway leading to activation of factor X, formation of thrombin, and conversion of fibrinogen to insoluble fibrin, which forms the clot structure[1][3][4]. This cascade is tightly regulated to prevent both excessive bleeding and abnormal clot formation, and disturbances contribute to a wide range of bleeding and thrombotic diseases[2][4][3].
Inhibition of specific coagulation factors to prevent clot formation (e.g., warfarin inhibits vitamin K-dependent factors); Direct inhibition of thrombin or factor Xa (e.g., direct oral anticoagulants); Activation of fibrinolysis to dissolve clots (e.g., tPA increases conversion of plasminogen to plasmin); Factor replacement to restore deficient factors in hemophilia.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation system (Coagulation cascade).